检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]青岛市海慈医疗集团,山东青岛266033 [2]山东中医药大学,济南250355 [3]青岛市第九人民医院,山东青岛266001
出 处:《中国实验方剂学杂志》2015年第8期182-185,共4页Chinese Journal of Experimental Traditional Medical Formulae
基 金:青岛市2013年度医药科研指导计划项目(2013-WSZD050)
摘 要:目的:观察补肾活血汤对慢性心力衰竭患者(CHF)临床疗效及对免疫炎症反应的影响。方法:将60例患者按随机数字表法分为两组,对照组30例用西医常规治疗,治疗组30例在对照组治疗基础上加服补肾活血汤,每日1剂,疗程14 d。观察两组临床症状积分、左室舒张末内径(LVED),左室射血分数(LVEF),血浆脑钠肽(BNP),肿瘤坏死因子-α(TNF-α),白介素-6(IL-6),长正五聚蛋白3(PTX-3)水平的变化。结果:治疗组临床症状积分改善的总有效率(90%)优于对照组(80%),两组比较差异有统计学意义(P<0.05)。治疗组治疗后[BNP(1 058.72±575.62)ng·L-1,IL-6(6.88±0.91)ng·L-1,TNF-α(251.54±52.72)ng·L-1,PTX-3(3.16±0.60)μg·L-1]均较对照组[(1 542.26±732.18)ng·L-1,(9.63±1.25)ng·L-1,(283.24±48.58)ng·L-1,(3.40±0.56)μg·L-1]明显改善(P<0.05),两组患者LVED,LVEF均较治疗前好转,但差异无统计学意义。结论:补肾活血汤可以显著改善CHF患者心功能,降低TNF-α,IL-6,BNP,PTX-3水平,抑制免疫炎症反应,改善预后。Objective: This study was conducted to observe the clinical efficacy of Bushen Huoxue decoction on patients with chronic heart failure (CHF), and its effect on immuno-inflammatory response. Method: In this study, sixty patients were divided into two groups by random number table, with 30 cases in the control group by routine western medicine treatment, while 30 cases in the treatment group treated by the combination of western conventional therapy with Bushen Huoxue decoction, taking a dose once for 14 days. We observed the changes of clinical symptom integrals, left ventricular end diastolic diameter (LVED) , left ventricular ejection fraction (LVEF), brain natriuretic peptide (BNP), tumor necrosis factor α (TNF-α), interleukin-6 (IL-6) and pentraxin-3 (PTX-3) in the two groups. Result: The total effective rate of clinical symptom integrals in the treatment group (90%) was improved better than the control group (80%) ( P 〈 0.05 ). The level of [BNP (1 058.72±575.62) ng·L^-1,IL-6 (6.88±0.91) ng·L^-1, TNF-α (251.54±52.72) ng·L^-1, PTX-3 (3. 16 ±0.60) μg·L^-1] in treatment group after treatment were improved significantly than the control group [ (1542.26±732.18)ng·L^-1, (9.63±1.25) ng·L^-1], (283.24±48.58) ng·L^-1, (3.40±0.56) μg·L^-1] (P 〈 0.05 ). The improvements in LVED and LVEF in the both groups were better than those before the treatment, but the difference was not statistically significant. Conclusion: Bushen Huoxue decoction could obviously improve the CHF patient's cardiac function, reduce the contents of TNF-α, IL-6, BNP and PTX-3, restrain immuno-inflammatory response and improve prognosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15